July 2014

5th Cancer Targets & Therapeutics Conference (July 7-8, 2014, Boston, MA) ( 9:00 am )

5th Cancer Targets & Therapeutics Conference (July 7-8, 2014, Boston, MA)

With the rapid progression of molecular biology and genetics, and the subsequent emergence of many new targets, emerging targets and therapeutics provide new opportunities for the prevention and treatment of several major disease systems. The 5th Cancer Targets & Therapeutics Conference, taking place on July 7-8, 2014 in Boston, MA will continue to be a premier event for translational researchers, preclinical scientists and managers, and those carrying out early phase clinical trials, working to identify and exploit advances in the field in order to deliver products with a meaningful clinical impact. Both cutting-edge researchers and those who guide its commercial development will be on-hand to share their knowledge and insights as to how therapeutic cancer targets are identified, and how this research translates into meaningful therapeutics that benefit patients living with cancer.


2014 Session Topics:
I. Bridging Genomics & Proteomics in Cancer
II. Cancer Biomarkers in Discovery & Clinical Trials
III. Emerging Cancer Targets & Therapeutic Strategies
- Kinse Inhibitors
- Epigenetic Regulators
- Metabolic Pathways
- Cancer Stem Cells
IV. Progress in Cancer Immunotherapy
V. Combination Strategies in Immuno-Oncology
VI. Clinical Drug Development

This conference is part of our larger Novel Cancer Therapeutics Summit 2014, which includes one additional parallel conference:

Novel Cancer Therapeutics Summit 2014:
2nd Oncology Partnering & Deal-Making
4th Cancer Targets & Therapeutics

Sign up for the Summit Pass to have access to both conferences of the summit!

Sponsorship and exhibiting opportunities are available in a range of levels, which can be tailored to fit your needs. Please contact 626-256-6405x110 or  This e-mail address is being protected from spambots. You need JavaScript enabled to view it  for more info.

Contact Info : Kristen Starkey 635 W. Foothill Blvd. Monrovia, CA 91016 Tel: (626) 256-6405 fax: (626) 466-4433 email: Email : Url: http://www.gtcbio.com/conference/cancer-targets-overview

5th Cancer Targets & Therapeutics Conference (July 7-8, 2014, Boston, MA) ( 9:00 am )

5th Cancer Targets & Therapeutics Conference (July 7-8, 2014, Boston, MA)

With the rapid progression of molecular biology and genetics, and the subsequent emergence of many new targets, emerging targets and therapeutics provide new opportunities for the prevention and treatment of several major disease systems. The 5th Cancer Targets & Therapeutics Conference, taking place on July 7-8, 2014 in Boston, MA will continue to be a premier event for translational researchers, preclinical scientists and managers, and those carrying out early phase clinical trials, working to identify and exploit advances in the field in order to deliver products with a meaningful clinical impact. Both cutting-edge researchers and those who guide its commercial development will be on-hand to share their knowledge and insights as to how therapeutic cancer targets are identified, and how this research translates into meaningful therapeutics that benefit patients living with cancer.


2014 Session Topics:
I. Bridging Genomics & Proteomics in Cancer
II. Cancer Biomarkers in Discovery & Clinical Trials
III. Emerging Cancer Targets & Therapeutic Strategies
- Kinse Inhibitors
- Epigenetic Regulators
- Metabolic Pathways
- Cancer Stem Cells
IV. Progress in Cancer Immunotherapy
V. Combination Strategies in Immuno-Oncology
VI. Clinical Drug Development

This conference is part of our larger Novel Cancer Therapeutics Summit 2014, which includes one additional parallel conference:

Novel Cancer Therapeutics Summit 2014:
2nd Oncology Partnering & Deal-Making
4th Cancer Targets & Therapeutics

Sign up for the Summit Pass to have access to both conferences of the summit!

Sponsorship and exhibiting opportunities are available in a range of levels, which can be tailored to fit your needs. Please contact 626-256-6405x110 or  This e-mail address is being protected from spambots. You need JavaScript enabled to view it  for more info.

Contact Info : Kristen Starkey 635 W. Foothill Blvd. Monrovia, CA 91016 Tel: (626) 256-6405 fax: (626) 466-4433 email: Email : Url: http://www.gtcbio.com/conference/cancer-targets-overview

12th Vaccines Research & Development: All Things Considered Conference (July 9-11, 2014, Boston, MA) ( 9:00 am )

12th Vaccines Research & Development: All Things Considered Conference (July 9-11, 2014, Boston, MA)

GTC is proud to present its 12th Vaccines Research & Development: All Things Considered Conference, to be held in Boston, MA on July 9-11, 2014. This conference continues a tradition of presenting valuable updates and exposure to all aspects of vaccine development, including research, product design considerations / specifications, manufacturing, regulations, investment, and policy, in a comfortable, interactive and friendly setting. It brings together the leaders in vaccinology from industry, academia, and the government for practical discussions of the future of our discipline.

Development of new vaccines truly requires a consideration of many things. We examine vaccine development from basic research to marketing. We bring together the people who make the discoveries, make the decisions, fund the work and license the vaccines and foster their interaction with the attendees to share their perspectives of the vaccine industry. The latest information on the new malaria, HIV, tumor, and therapeutic vaccines, DNA vaccines, RNA vaccines, adjuvants, mucosal and other delivery mechanisms will be presented, as will updates on governmental priorities, funding and partnership opportunities.

Contact Info : Kristen Starkey 635 W. Foothill Blvd. Monrovia, CA 91016 Tel: (626) 256-6405 fax: (626) 466-4433 email: Email : Url: http://www.gtcbio.com/conference/vaccines-research-and-development-overview

12th Vaccines Research & Development: All Things Considered Conference (July 9-11, 2014, Boston, MA) ( 9:00 am )

12th Vaccines Research & Development: All Things Considered Conference (July 9-11, 2014, Boston, MA)

GTC is proud to present its 12th Vaccines Research & Development: All Things Considered Conference, to be held in Boston, MA on July 9-11, 2014. This conference continues a tradition of presenting valuable updates and exposure to all aspects of vaccine development, including research, product design considerations / specifications, manufacturing, regulations, investment, and policy, in a comfortable, interactive and friendly setting. It brings together the leaders in vaccinology from industry, academia, and the government for practical discussions of the future of our discipline.

Development of new vaccines truly requires a consideration of many things. We examine vaccine development from basic research to marketing. We bring together the people who make the discoveries, make the decisions, fund the work and license the vaccines and foster their interaction with the attendees to share their perspectives of the vaccine industry. The latest information on the new malaria, HIV, tumor, and therapeutic vaccines, DNA vaccines, RNA vaccines, adjuvants, mucosal and other delivery mechanisms will be presented, as will updates on governmental priorities, funding and partnership opportunities.

Contact Info : Kristen Starkey 635 W. Foothill Blvd. Monrovia, CA 91016 Tel: (626) 256-6405 fax: (626) 466-4433 email: Email : Url: http://www.gtcbio.com/conference/vaccines-research-and-development-overview

11th Anti-infectives Partnering And Deal-Making Conference (July 10-11, 2014, Boston, MA) ( 9:00 am )

11th Anti-infectives Partnering and Deal-Making Conference (July 10-11, 2014, Boston, MA)

GTC's 11th Anti-infectives Partnering and Deal-Making Conference, taking place on July 10-11, 2014 in Boston, MA, will contribute to the on-going battle against the ever-changing infectious threats by having experts with direct experiences in the field discuss a wide variety of topics on infectious diseases. The agenda also allows time for networking and opportunities to interface with speakers and fellow delegates in a collegial setting. Previous GTC conferences have been catalytic to several successful partnerships and in 2014 we expect this trend to continue.

GTC’s Anti-Infectives Partnering & Deal Making is an infectious disease partnering and business development conference that gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, explore potential collaborations, and learn about relevant anti-infective issues and deals that will affect the industry. This event also provides a unique venue for attendees to learn about the anti-infective business development trends, the infectious disease markets, and novel technologies that shape up the industry.

Contact Info:
Kristen Starkey
635 W. Foothill Blvd. Monrovia, CA 91016
Tel: (626) 256-6405
fax: (626) 466-4433
email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Url: http://www.gtcbio.com/conference/anti-infectives-partnering-and-deal-making-overview

12th Vaccines Research & Development: All Things Considered Conference (July 9-11, 2014, Boston, MA) ( 9:00 am )

12th Vaccines Research & Development: All Things Considered Conference (July 9-11, 2014, Boston, MA)

GTC is proud to present its 12th Vaccines Research & Development: All Things Considered Conference, to be held in Boston, MA on July 9-11, 2014. This conference continues a tradition of presenting valuable updates and exposure to all aspects of vaccine development, including research, product design considerations / specifications, manufacturing, regulations, investment, and policy, in a comfortable, interactive and friendly setting. It brings together the leaders in vaccinology from industry, academia, and the government for practical discussions of the future of our discipline.

Development of new vaccines truly requires a consideration of many things. We examine vaccine development from basic research to marketing. We bring together the people who make the discoveries, make the decisions, fund the work and license the vaccines and foster their interaction with the attendees to share their perspectives of the vaccine industry. The latest information on the new malaria, HIV, tumor, and therapeutic vaccines, DNA vaccines, RNA vaccines, adjuvants, mucosal and other delivery mechanisms will be presented, as will updates on governmental priorities, funding and partnership opportunities.

Contact Info : Kristen Starkey 635 W. Foothill Blvd. Monrovia, CA 91016 Tel: (626) 256-6405 fax: (626) 466-4433 email: Email : Url: http://www.gtcbio.com/conference/vaccines-research-and-development-overview

11th Anti-infectives Partnering And Deal-Making Conference (July 10-11, 2014, Boston, MA) ( 9:00 am )

11th Anti-infectives Partnering and Deal-Making Conference (July 10-11, 2014, Boston, MA)

GTC's 11th Anti-infectives Partnering and Deal-Making Conference, taking place on July 10-11, 2014 in Boston, MA, will contribute to the on-going battle against the ever-changing infectious threats by having experts with direct experiences in the field discuss a wide variety of topics on infectious diseases. The agenda also allows time for networking and opportunities to interface with speakers and fellow delegates in a collegial setting. Previous GTC conferences have been catalytic to several successful partnerships and in 2014 we expect this trend to continue.

GTC’s Anti-Infectives Partnering & Deal Making is an infectious disease partnering and business development conference that gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, explore potential collaborations, and learn about relevant anti-infective issues and deals that will affect the industry. This event also provides a unique venue for attendees to learn about the anti-infective business development trends, the infectious disease markets, and novel technologies that shape up the industry.

Contact Info:
Kristen Starkey
635 W. Foothill Blvd. Monrovia, CA 91016
Tel: (626) 256-6405
fax: (626) 466-4433
email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Url: http://www.gtcbio.com/conference/anti-infectives-partnering-and-deal-making-overview